Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00683137 · ClinicalTrials.gov registry record · Phase 3
Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery
A Phase 3 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 450
- Enrollment target
NCT00683137 is a Phase 3 study that has completed, run by Pfizer. The registered enrollment target is 450 participants.
The verdict
NCT00683137, a Phase 3 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 450 participants
- Enrollment target
Study Summary
The study was done to evaluate the pain relief and safety of 2 valdecoxib doses compared to placebo in patients with moderate or severe pain following bunionectomy surgery, and to evaluate the effect of the 2 valdecoxib doses compared to placebo on health outcome measures and on the occurrence of opioid related symptoms.
Interventions
- DRUG valdecoxib
- DRUG valdecoxib/placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2002-10 |
| Est. Completion | 2003-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00683137
The ClinicalTrials.gov registry entry for NCT00683137 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which valdecoxib is the first listed.
NCT00683137 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00683137 about?
NCT00683137 is a clinical study titled "Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery". The study was done to evaluate the pain relief and safety of 2 valdecoxib doses compared to placebo in patients with moderate or severe pain following bunionectomy surgery, and to evaluate the effect of the 2 valdecoxib doses compared to placebo on health outcome measures and on the occurrence of op...
What is the current status of trial NCT00683137?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 450 participants. The study started on 2002-10. Estimated completion is 2003-02.
What interventions are being tested in trial NCT00683137?
The interventions under investigation include: valdecoxib (DRUG), valdecoxib/placebo (DRUG).
Who is sponsoring clinical trial NCT00683137?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.